« Back

Detlef joined Satsuma Pharmaceuticals in 2017 as our Chief Medical Officer. Detlef’s biopharmaceutical industry experience spans more than 29 years and includes CMO, CEO, board of directors, executive leadership, and head of research & development positions in discovery-, clinical and commercial-stage public and private companies. Prior to Satsuma, Detlef served as Head of R&D at Armetheon from 2015 to 2017. Before that Detlef was Chief Executive Officer and President of Sorbent Therapeutics, Inc.  from 2010 to 2014. From 2004 through 2009 Detlef served as Chief Medical Officer and Senior Vice President of Research and Development at Ilypsa and Relypsa, which he co-founded. Prior to that he served as Vice President of Clinical Development and Member of the Management Board of ALZA Corporation from 1999 to 2004. Detlef started his industry career in 1992 at Schwarz Pharma in Germany. During his tenure in the biopharmaceutical industry, Detlef was responsible for supporting the development, registration, and commercialization of a range of urology (EDEX®, Ditropan XL®, Elmiron®, Viadur®, Priligy®) oncology (DOXIL®), pain (DURAGESIC®, E-trans fentanyl), CNS (CONCERTA®), and cardiovascular products (KIKLIN®, VELTASSA®) in North America, Europe and Japan. Detlef received his MD degree from the Rheinisch Westfälische Technische Hochschule in Aachen, Germany in 1988.